Definitive diagnosis of FTDP-17 requires a combination of characteristic clinical and pathological features and molecular genetic analysis.
To diagnose FTDP-17 accurately, clinicians rely on both the patient's symptoms and the presence of specific pathological changes in the brain, along with molecular genetic analysis to confirm the diagnosis.